4-Hydroxymephenytoin

CAS No. 61837-65-8

4-Hydroxymephenytoin( (+/-)-4'-Hydroxymephenytoin )

Catalog No. M26029 CAS No. 61837-65-8

4-Hydroxymephenytoin is the metabolism of an antiepileptic drug mephenytoin. Mephenytoin is used as a CYP2C19 substrate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 Get Quote
10MG 102 Get Quote
25MG 205 Get Quote
50MG 335 Get Quote
100MG 537 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    4-Hydroxymephenytoin
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Hydroxymephenytoin is the metabolism of an antiepileptic drug mephenytoin. Mephenytoin is used as a CYP2C19 substrate.
  • Description
    4-Hydroxymephenytoin is the metabolism of an antiepileptic drug mephenytoin. Mephenytoin is used as a CYP2C19 substrate.(In Vitro):4-Hydroxymephenytoin is a metabolism of mephenytoin, which is an antiepileptic drug, and used as a CYP2C19 substrate. 4-Hydroxymephenytoin is used for developing UltraPerformance LC (UPLC) tandem mass spectrometry assays for evaluating CYP probe drugs and their relevant metabolites in human urine or plasma samples.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (+/-)-4'-Hydroxymephenytoin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    61837-65-8
  • Formula Weight
    234.255
  • Molecular Formula
    C12H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (426.89 mM)
  • SMILES
    CCC1(NC(=O)N(C)C1=O)c1ccc(O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sonneck M, et al. Crystal structure of (E)-undec-2-enoic acid. Acta Crystallogr E Crystallogr Commun. 2015 May 28;71(Pt 6):o426-7.
molnova catalog
related products
  • PF-04937319

    PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.

  • 3-Chloropropiophenon...

    3-Chloropropiophenone is a small molecular compound.

  • GAC0003A4

    GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.